Nuvectis Pharma
NVCT
NVCT
12 hedge funds and large institutions have $10M invested in Nuvectis Pharma in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 0 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.63% more ownership
Funds ownership: 5.06% → 9.68% (+4.6%)
Holders
12
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$4.49M | |
| 2 | +$1.02M | |
| 3 | +$85.1K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$52.8K |
| 5 |
BlackRock
New York
|
+$48.6K |